# FDA Inspection 1255732 - Department of Defense - Army - November 12, 2024

Source: https://www.keypedia.com/records/fda_inspections/department-of-defense-army/03a5d970-e286-4463-a20e-0dd08bd61203
Source feed: FDA_Inspections

> FDA Inspection 1255732 for Department of Defense - Army on November 12, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1255732
- Company Name: Department of Defense - Army
- Inspection Date: 2024-11-12
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1255732 - 2024-11-12](https://www.keypedia.com/records/fda_inspections/department-of-defense-army/52378bb2-829f-442e-9d2f-08659387382f)
- [FDA Inspection 1091692 - 2019-05-15](https://www.keypedia.com/records/fda_inspections/department-of-defense-army/0befa415-c918-4284-8991-292422b150a4)
- [FDA Inspection 1006805 - 2017-03-15](https://www.keypedia.com/records/fda_inspections/department-of-defense-army/53083a71-fccd-487a-97cb-78fc0140e1cb)
- [FDA Inspection 915802 - 2015-02-24](https://www.keypedia.com/records/fda_inspections/department-of-defense-army/ac070ac6-9086-401c-aaab-59c720fa3eec)
- [FDA Inspection 820252 - 2013-02-26](https://www.keypedia.com/records/fda_inspections/department-of-defense-army/3a0a3fff-7f1f-4148-8421-d8f92e5f58f1)

Company: https://www.keypedia.com/companies/department-of-defense-army/c187bf85-3694-4fe4-9f41-b97caf415f74

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d